-
Loading metrics
Can 17 hydroxyprogesterone caproate (17P) decrease preterm deliveries in patients with a history of PMC or pPROM?
-
Gal Cohen ,
Roles Conceptualization, Data curation, Methodology, Project administration, Writing – original draft
* E-mail: galcwork@gmail.com
Affiliations Department of Obstetrics and Gynecology, Meir Medical Center, Kfar-Saba, Israel, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
⨯ - Maya Shavit,
- Netanella Miller,
- Rimon Moran,
- Yael Yagur,
- Omer Weitzner,
- Michal Ovadia,
- Hanoch Schreiber,
- Gil Shechter-Maor,
- Tal Biron-Shental
https://orcid.org/0000-0001-7944-0532
Can 17 hydroxyprogesterone caproate (17P) decrease preterm deliveries in patients with a history of PMC or pPROM?
- Gal Cohen,
- Maya Shavit,
- Netanella Miller,
- Rimon Moran,
- Yael Yagur,
- Omer Weitzner,
- Michal Ovadia,
- Hanoch Schreiber,
- Gil Shechter-Maor,
- Tal Biron-Shental
x
- Published: May 12, 2022
- https://doi.org/10.1371/journal.pone.0268397